Riik: Iisrael
keel: inglise
Allikas: Ministry of Health
EXEMESTANE
ABIC MARKETING LTD, ISRAEL
L02BG06
FILM COATED TABLETS
EXEMESTANE 25 MG
PER OS
Required
PHAROS GENERICS LTD, CYPRUS
EXEMESTANE
Exemestane Teva® is indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. Exemestane Teva® is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies.Exemestane Teva® is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy
2018-05-31
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986 The medicine is dispensed with a doctor’s prescription only EXEMESTANE TEVA 25 MG FILM-COATED TABLETS COMPOSITION Each film-coated tablet contains: Exemestane 25 mg. For a list of the inactive ingredients, please see section 6, and also see section 2 “Important information about some of the ingredients of the medicine”. READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, refer to the doctor or pharmacist. This medicine has been prescribed for the treatment of your ailment. Do not pass it on to others. It may harm them, even if it seems to you that their ailment is similar. This medicine is not intended for children. 1. WHAT IS THE MEDICINE INTENDED FOR? Exemestane Teva 25 mg is used to treat early-stage hormone- dependent breast cancer in postmenopausal women after they have already completed 2-3 years of treatment with the medicine tamoxifen. In addition, Exemestane Teva 25 mg is used to treat advanced hormone-dependent breast cancer in postmenopausal )naturally or induced) women, whose disease progressed after a single hormonal treatment or after several hormonal treatments )anti-estrogenic). THERAPEUTIC GROUP: Steroidal inhibitors of the aromatase enzyme, anti-neoplastic )anti-cancer) agents. Exemestane Teva 25 mg belongs to a group of aromatase inhibitors - the enzyme needed, especially in postmenopausal women, to produce the female sex hormones, estrogens. Reduction in estrogen levels in the body is a way of treating hormone-dependent breast cancer. 2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF YOU ARE: - Sensitive )allergic) or have been sensitive in the past, to the active ingredient )exemestane) or to any of the additional ingredients contained in the medicine )for further information please see section 6) - Pregnant, may be pregnant or breastfeeding - Before menopause )you still have mo Lugege kogu dokumenti